Cite

HARVARD Citation

    Lopes, L. et al. (2013). Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta‐Analysis. Clinical pharmacology & therapeutics. 94 (3), pp. 367-375. [Online]. 
  
Back to record